Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective

PURPOSE: To evaluate the cost-effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) vs twice-daily budesonide/formoterol (BUD/FOR) in patients with symptomatic chronic obstructive pulmonary disease (COPD) at risk of exacerbations, from the Spanish National Healthcare S...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Melanie, Benjamin, Nicole, Atienza, Laura, Biswas, Chandroday, Martin, Alan, Whalen, John D, Izquierdo Alonso, José Luis, Riesco Miranda, Juan Antonio, Soler-Cataluña, Juan José, Huerta, Alicia, Ismaila, Afisi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360413/
https://www.ncbi.nlm.nih.gov/pubmed/32764908
http://dx.doi.org/10.2147/COPD.S240556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360413/
https://www.ncbi.nlm.nih.gov/pubmed/32764908
http://dx.doi.org/10.2147/COPD.S240556

Ejemplares similares